Tenex

   
Google
 
Web NewDrugInformation.com

Tenex


Drug - Tenex
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Guanfacine Hydrochloride
Multiple ingredients are in alphabetical order.

Strength - EQ 1MG BASE
The potency of the active ingredient(s), Guanfacine Hydrochloride. May repeat for multiple part products.

Applicant - ESP PHARMA
The firm name holding legal responsibility for Tenex. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 019032
The FDA assigned number to Tenex. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Tenex. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Oct 27, 1986
The date Tenex was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Tenex. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Tenex is in. Format is RX, OTC, DISCN.

Applicant Full Name - Esp Pharma Inc
The full name of the firm holding legal responsibility for the new application of Tenex.

Tenex